Substances under S2.2.3 are non-Specified Substances under the WADA Code
The transition protocol from tirzepatide provides specific guidance for this switch
For the next few weeks, the drug took a toll on her mental and physical health
Approximately 70% of American adults are obese or overweight, a severe health issue associated with heart disease, stroke, and diabetes, linked to an increased risk of certain types of cancer
It's important to acknowledge that these are common, with studies indicating that a significant percentage of users (reports range from 40% up to 85%) experience issues like nausea, vomiting, diarrhea, constipation, bloating, or heartburn, particularly when first starting the medication or increasing the dose
C., de Lartigue, G